Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis
Epithelial-mesenchymal Transition (EMT) is a de-differentiation program that imparts tumor cells with the phenotypic and cellular plasticity required for drug resistance, metastasis, and recurrence. This dynamic and reversible events is governed by a network of EMT-transcription factors (EMT-TFs) th...
Main Authors: | Yifan Wang, Chenfang Dong, Binhua P. Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2020-06-01
|
Series: | Genes and Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304219300844 |
Similar Items
-
Regulation of snail in epithelial-mesenchymal transition and breast cancer progression and metastasis
by: Binhua P. Zhou
Published: (2017-03-01) -
Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition
by: Monica Fedele, et al.
Published: (2021-10-01) -
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
by: Monica Fedele, et al.
Published: (2022-01-01) -
Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism
by: Aspuria, Paul-Joseph P., et al.
Published: (2014) -
Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition
by: Wan Hua, et al.
Published: (2021-09-01)